2020-9-24 · J TRANSL MED/Journal of Translational MedicineIF 4.124 OA 732 44.84 Monthly 1.3 2.3
2016-8-1 · Section edited by Davide Bedognetti. The Cancer microenvironment section publishes research on the cellular and molecular components of the cancer microenvironment with a particular focus on translational research that has important implications for the prevention diagnosis and treatment of human neoplasms.
2021-7-4 · Journal of Translational Medicine 2019 2 TOP MEDICINE RESEARCH EXPERIMENTAL 2 Journal of Translational Medicine
2021-7-21 · The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) a nonprofit international scientific and professional organization—offers readers around the globe clinical investigations basic science reports continuing education articles book reviews employment opportunities and updates on rapidly changing issues in practice and
Change of Journal Title From TGC to TGH . On March 1st 2016 the TGC editorial office has decided to change the original journal title from Translational Gastrointestinal Cancer to Translational Gastroenterology and Hepatology. The advances are listed as below • To cover a broader journal scope including gastroenterology and hepatology.
Editor-in-chief. Translational Research (formerly The Journal of Laboratory and Clinical Medicine) delivers original investigations in the broad fields of laboratory clinical and public health research. Published monthly since 1915 it keeps readers up-to-date on significant biomedical research from all subspecialties of
Translational Gastrointestinal Cancer (Transl Gastrointest Cancer Print ISSN 2224-476X Online ISSN 2224-4778) publishes articles that describe new findings in the field of translational research in gastrointestinal cancers provides current and practical information on diagnosis prevention and clinical investigations of gastrointestinal cancers.
Translational Gastrointestinal Cancer (Transl Gastrointest Cancer Print ISSN 2224-476X Online ISSN 2224-4778) publishes articles that describe new findings in the field of translational research in gastrointestinal cancers provides current and practical information on diagnosis prevention and clinical investigations of gastrointestinal cancers.
2021-7-15 · The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control (UICC).IJC has a global readership and receives over 3 000 submissions a year under a broad scope of topics relevant to experimental and clinical cancer research. We invite and encourage original Research Articles and Short Reports.
Change of Journal Title From TGC to TGH . On March 1st 2016 the TGC editorial office has decided to change the original journal title from Translational Gastrointestinal Cancer to Translational Gastroenterology and Hepatology. The advances are listed as below • To cover a broader journal scope including gastroenterology and hepatology.
The 2019-2020 Journal Impact IF of Translational Cancer Research is 0.986 which is just updated in 2020. The highest Journal Impact IF of Translational Cancer Research is 2.183. The lowest Journal Impact IF of Translational Cancer Research is 0.986. The total growth rate of Translational Cancer Research
Translational Cancer Research publishes the results of novel research investigations including risk assessment cellular and prevention detection diagnosis and treatment of human cancers.
Editor-in-chief. Translational Research (formerly The Journal of Laboratory and Clinical Medicine) delivers original investigations in the broad fields of laboratory clinical and public health research. Published monthly since 1915 it keeps readers up-to-date on significant biomedical research from all subspecialties of
Aging AND Cancer is a quarterly peer-reviewed international open access journal that is focused on understanding how the process of aging is a central component of cancer evolution and progression.The journal will cover basic translational and clinical findings that are of broad interest investigating the biology of and/or mechanisms via which age-associated deterioration of the individual
Journal description. Journal of Translational Medicine is ready to receive papers on all aspects of information derived from human experimentation in the realm of translational medicine.
Translational Gastrointestinal Cancer (Transl Gastrointest Cancer Print ISSN 2224-476X Online ISSN 2224-4778) publishes articles that describe new findings in the field of translational research in gastrointestinal cancers provides current and practical information on diagnosis prevention and clinical investigations of gastrointestinal cancers.
Translational Cancer Research is an international open access peer-reviewed journal indexed in Scopus and Science Citation Index Expanded (SCIE) focusing on original science-based researches on clinical basic and translational aspects. It publishes laboratory studies of novel therapeutic interventions clinical trials which evaluate new
Editorial Board 2010 American Journal of Translational Research (ISSN 1943-8141) ajtr Publisher e-Century Publishing Corporation (e-Century) Prostate cancer (PCa) is the
Translational Cancer Research publishes the results of novel research investigations including risk assessment cellular and prevention detection diagnosis and treatment of human cancers.
2021-7-9 · American Journal of Translational Research (official SCI Impact Factor 2.829) is an online open-access medical journal dedicated to the translational research in medicine (translational medicine)including basic and clinical translational sciences in oncology cardiology neurology pharmacology and all related medical research.
Translational Cancer Research is an international open access peer-reviewed journal indexed in Scopus and Science Citation Index Expanded (SCIE) focusing on original science-based researches on clinical basic and translational aspects. It publishes laboratory studies of novel therapeutic interventions clinical trials which evaluate new
2020-6-22 · Aims and Scope. Translational Breast Cancer Research (Transl Breast Cancer Res TBCR Online ISSN 2218-6778) launched in November 2019 is an open access peer-reviewed journal focusing on translational research in breast cancer.. As a quarterly published journal the journal seeks to create a platform for researchers and clinicians by presenting pertinent investigations for discussing
2018-12-18 · Translational oncology has become mainstream oncology—it is what we do each day in the laboratory and in the clinic. Over the last few years the Journal of Clinical Oncology ( JCO) has produced a series on translational oncology topics and original papers. The series was received with enthusiasm by our readers as well as basic and clinical
Editorial Board 2010 American Journal of Translational Research (ISSN 1943-8141) ajtr Publisher e-Century Publishing Corporation (e-Century) Prostate cancer (PCa) is the
The Journal for ImmunoTherapy of Cancer (JITC) is the open access peer reviewed journal that publishes on all aspects of tumor immunology and cancer immunotherapy aiming to enrich communication and advance scientific understanding in this rapidly evolving field ics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions the tumor
Translational Cancer Research publishes the results of novel research investigations including risk assessment cellular and prevention detection diagnosis and treatment of human cancers.
Translational Gastrointestinal Cancer (Transl Gastrointest Cancer Print ISSN 2224-476X Online ISSN 2224-4778) publishes articles that describe new findings in the field of translational research in gastrointestinal cancers provides current and practical information on diagnosis prevention and clinical investigations of gastrointestinal cancers.
Annals of Translational Medicine is an international peer-reviewed Open Access journal featuring original and observational investigations in the broad fields of laboratory clinical and public health research including but are not limited to oncology thoracic disease cardiology hepatology gastroenterology endocrinology neurology
Journal of Translational Medicine therefore levies an article-processing charge of £1370/ 2145/€1745 for each article accepted for publication. If the corresponding author s institution participates in our open access membership program some or all of the publication cost may be covered (more details available on the membership page ).
2021-7-4 · Journal of Translational Medicine 2019 2 TOP MEDICINE RESEARCH EXPERIMENTAL 2 Journal of Translational Medicine
2020-3-4 · Lung cancer is a heterogeneous group of diseases at both the histopathological and molecular levels. Individual treatment plans should be based on the histological and molecular characteristics of the tumour as well as stage of disease at diagnosis performance status and co-morbidities. Surgery radiotherapy drugs including chemotherapy targeted agents and immunotherapy alongside expert
2021-7-21 · The Journal of Nuclear Medicine (JNM)—self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) a nonprofit international scientific and professional organization—offers readers around the globe clinical investigations basic science reports continuing education articles book reviews employment opportunities and updates on rapidly changing issues in practice and
The 2019-2020 Journal Impact IF of Translational Cancer Research is 0.986 which is just updated in 2020. The highest Journal Impact IF of Translational Cancer Research is 2.183. The lowest Journal Impact IF of Translational Cancer Research is 0.986. The total growth rate of Translational Cancer Research
2021-7-17 · Research Progress of Translational Medicine in Breast Cancer J . Journal of International Translational Medicine 2017 5 (2) 86-91. 1 Rebecca R Ma JM Zou ZH et al. Cancer statistics 2014. Ca Cancer J Clin 2014 64 (5) 364. doi 10.3322/caac.21208. 2 Guo F Liu ZZ Liu HB et al. P53 gene could be a new effective therapeutic target in
Translational Science Journal is an open access journal with comprehensive peer review policy and a rapid publication process. JTS is a novel journal that will focus upon the translation of cellular molecular and genetic pathways into clinical strategies for multiple medical disciplines.
2021-6-1 · Ultimovacs Announces Publication in The Journal of Translational Medicine on Mechanistic Rationale of UV1 Cancer Vaccine Supporting Phase 2 Study Design in Malignant Mesotheliomaread this article along with other careers information tips and advice on BioSpace
Journal description. Journal of Translational Medicine is ready to receive papers on all aspects of information derived from human experimentation in the realm of translational medicine.
The 2019-2020 Journal Impact IF of Translational Cancer Research is 0.986 which is just updated in 2020. The highest Journal Impact IF of Translational Cancer Research is 2.183. The lowest Journal Impact IF of Translational Cancer Research is 0.986. The total growth rate of Translational Cancer Research IF is -51.5 .
Cancer Medicine is a peer-reviewed open access interdisciplinary journal providing rapid publication of research from global biomedical researchers across the cancer sciences in the areas of but not limited to cancer biology clinical cancer research and cancer prevention. We would like to invite you to submit your paper to Cancer Medicine.
Aging AND Cancer is a quarterly peer-reviewed international open access journal that is focused on understanding how the process of aging is a central component of cancer evolution and progression.The journal will cover basic translational and clinical findings that are of broad interest investigating the biology of and/or mechanisms via which age-associated deterioration of the individual
2020-3-4 · Lung cancer is a heterogeneous group of diseases at both the histopathological and molecular levels. Individual treatment plans should be based on the histological and molecular characteristics of the tumour as well as stage of disease at diagnosis performance status and co-morbidities. Surgery radiotherapy drugs including chemotherapy targeted agents and immunotherapy alongside expert
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
